Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy.

Elizabeth A SuarezKrista F HuybrechtsLoreen StraubSonia Hernández-DíazHendrée E JonesHilary S ConneryJonathan M DavisKathryn J GrayBarry LesterMishka TerplanHelen MogunBrian T Bateman

Published in: The New England journal of medicine (2022)

The use of buprenorphine in pregnancy was associated with a lower risk of adverse neonatal outcomes than methadone use; however, the risk of adverse maternal outcomes was similar among persons who received buprenorphine and those who received methadone. (Funded by the National Institute on Drug Abuse.).

Keyphrases

pregnancy outcomes
preterm birth
quality improvement
pregnant women
type diabetes
metabolic syndrome
adipose tissue
skeletal muscle
physical activity
insulin resistance
birth weight
intimate partner violence
gestational age